Autonomix medical, inc. (nasdaq: amix) participates in virtual investor “what this means” segment highlighting key learnings from first-in-human trial and extension into visceral cancer pain

Dr. robert schwartz, chief medical officer of autonomix, discusses key learnings from initial trial phase (“poc 1”) where clinically meaningful pain reduction was demonstrated

AMIX Ratings Summary

AMIX Quant Ranking